LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates
Purcell, James W, Tanlimco, Sonia G, Hickson, Jonathan, Fox, Melvin, Sho, Mien, Durkin, Lisa, Uziel, Tamar, Powers, Rick, Foster, Kelly, McGonigal, Thomas, Kumar, Subashri, Samayoa, Josue, Zhang, Dong, Palma, Joann P, Mishra, Sasmita, Hollenbaugh, Diane, Gish, Kurt, Morgan-Lappe, Susan E, Hsi, Eric D, Chao, Debra T
Published in Cancer research (Chicago, Ill.) (15.07.2018)
Published in Cancer research (Chicago, Ill.) (15.07.2018)
Get full text
Journal Article
Immune oncology, immune responsiveness and the theory of everything
Turan, Tolga, Kannan, Deepti, Patel, Maulik, Matthew Barnes, J, Tanlimco, Sonia G, Lu, Rongze, Halliwill, Kyle, Kongpachith, Sarah, Kline, Douglas E, Hendrickx, Wouter, Cesano, Alessandra, Butterfield, Lisa H, Kaufman, Howard L, Hudson, Thomas J, Bedognetti, Davide, Marincola, Francesco, Samayoa, Josue
Published in Journal for immunotherapy of cancer (05.06.2018)
Published in Journal for immunotherapy of cancer (05.06.2018)
Get full text
Journal Article
Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR
Purcell, James W, Kim, Han K, Tanlimco, Sonia G, Doan, Minhtam, Fox, Melvin, Lambert, Peter, Chao, Debra T, Sho, Mien, Wilson, Keith E, Starling, Gary C, Culp, Patricia A
Published in Frontiers in immunology (2014)
Published in Frontiers in immunology (2014)
Get full text
Journal Article